CVS Health
CVS
1,707 hedge funds and large institutions have $55.1B invested in CVS Health in 2019 Q1 according to their latest regulatory filings, with 148 funds opening new positions, 855 increasing their positions, 596 reducing their positions, and 198 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 855 | Existing positions reduced: 596
3.41% less ownership
Funds ownership: 82.16% → 78.75% (-3.4%)
4% less funds holding
Funds holding: 1,779 → 1,707 (-72)
20% less capital invested
Capital invested by funds: $69.2B → $55.1B (-$14.1B)
22% less call options, than puts
Call options by funds: $1.12B | Put options by funds: $1.44B
25% less first-time investments, than exits
New positions opened: 148 | Existing positions closed: 198
58% less funds holding in top 10
Funds holding in top 10: 83 → 35 (-48)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$273M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$247M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$234M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$228M |
| 5 |
State Street
Boston,
Massachusetts
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$676M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$616M |
| 3 |
GCM
Glenview Capital Management
New York
|
-$556M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$495M |
| 5 |
Diamond Hill Capital Management
Columbus,
Ohio
|
-$280M |
CVS Hedge Fund Activity: Q1 2019 in Review
1,707 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2019, worth a combined $55.1B — down 20% from $69.2B a quarter earlier.
Sellers outnumbered buyers: 198 funds closed out of CVS and 148 opened new positions — a net loss of 50 holders — while 596 trimmed existing stakes and 855 added.
The largest buyer was Susquehanna International Group, adding an estimated $273M. The largest seller was JP Morgan Chase, cutting an estimated $676M.
- 1,707 institutional investors held CVS Health (CVS) as of Q1 2019, down from 1,779 in Q4 2018.
- Funds reported $55.1B of CVS Health stock for Q1 2019, down 20% quarter-over-quarter.
- 148 funds opened new CVS Health positions in Q1 2019 and 198 closed out, a net change of -50 holders.
- The largest CVS Health buyer in Q1 2019 was Susquehanna International Group, an estimated $273M added.
- The largest CVS Health seller in Q1 2019 was JP Morgan Chase, an estimated $676M sold.
Based on aggregated 13F filings for Q1 2019.